ZestAmigo
All companies
Syndax Pharmaceuticals logo

Syndax Pharmaceuticals

Biotechnology

New York City, New York, United States
200-500 employees
Founded 2005

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company focused on oncology, with two commercially approved medicines: Revuforj (revumenib) and Niktimvo (axatilimab).

  • Revuforj (revumenib)
  • Niktimvo (axatilimab)

Open roles at Syndax Pharmaceuticals

1 matching role

  • Senior Director, Alliance Management

    Unspecified

    New York City, New York, United States +1 more

    Director

    $270k to $290k USD

    • Management Occupations
    • Development

    Posted 3 days ago

    Source: Greenhouse

Showing 1 of 1 roles